甲胎蛋白显著升高的原发性肝小细胞神经内分泌癌1例

李庆麟; 王海晨; 孙俊英; 韩绍奇; 田虎

doi:10.3969/j.issn.1009-9905.2026.05.015

中国现代普通外科进展 ›› 2026, Vol. 29 ›› Issue (5) : 417 -420. DOI: 10.3969/j.issn.1009-9905.2026.05.015

病例报告

甲胎蛋白显著升高的原发性肝小细胞神经内分泌癌1例

李庆麟 ¹ ,
王海晨 ¹ ,
孙俊英 ² ,
韩绍奇 ¹ ,
田虎 ¹

作者信息 +

Author information +

文章历史 +

PDF (11626K)

摘要

关键词

肝脏肿瘤 / 甲胎蛋白 / 小细胞神经内分泌癌 / PET-CT / 病理诊断

Key words

引用本文

引用格式 ▾

[Author(id=1276248297002529551, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={CN=AuthorExt(id=1276248297065444113, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, authorId=1276248297002529551, language=CN, stringName=李庆麟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=¹, address=¹ 山东第一医科大学第一附属医院（山东省千佛山医院）普通外科（山东济南 250000）, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1276248296880894730, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, xref=1, ext=[AuthorCompanyExt(id=1276248296897671947, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, companyId=1276248296880894730, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=¹ 山东第一医科大学第一附属医院（山东省千佛山医院）普通外科（山东济南 250000）)])]), Author(id=1276248297115775763, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={CN=AuthorExt(id=1276248297170301717, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, authorId=1276248297115775763, language=CN, stringName=王海晨, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=¹, address=¹ 山东第一医科大学第一附属医院（山东省千佛山医院）普通外科（山东济南 250000）, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1276248296880894730, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, xref=1, ext=[AuthorCompanyExt(id=1276248296897671947, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, companyId=1276248296880894730, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=¹ 山东第一医科大学第一附属医院（山东省千佛山医院）普通外科（山东济南 250000）)])]), Author(id=1276248297216439063, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={CN=AuthorExt(id=1276248297270965017, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, authorId=1276248297216439063, language=CN, stringName=孙俊英, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=², address=² 山东第一医科大学第一附属医院（山东省千佛山医院）病理科（山东济南 250000）, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1276248296943809292, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, xref=2, ext=[AuthorCompanyExt(id=1276248296960586509, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, companyId=1276248296943809292, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=² 山东第一医科大学第一附属医院（山东省千佛山医院）病理科（山东济南 250000）)])]), Author(id=1276248297325490971, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={CN=AuthorExt(id=1276248297384211229, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, authorId=1276248297325490971, language=CN, stringName=韩绍奇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=¹, address=¹ 山东第一医科大学第一附属医院（山东省千佛山医院）普通外科（山东济南 250000）, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1276248296880894730, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, xref=1, ext=[AuthorCompanyExt(id=1276248296897671947, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, companyId=1276248296880894730, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=¹ 山东第一医科大学第一附属医院（山东省千佛山医院）普通外科（山东济南 250000）)])]), Author(id=1276248297430348575, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=tianhu6585@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={CN=AuthorExt(id=1276248297489068833, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, authorId=1276248297430348575, language=CN, stringName=田虎, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=¹, address=¹ 山东第一医科大学第一附属医院（山东省千佛山医院）普通外科（山东济南 250000）, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1276248296880894730, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, xref=1, ext=[AuthorCompanyExt(id=1276248296897671947, tenantId=1045748351789510663, journalId=1263062189734019109, articleId=1276240075508842631, companyId=1276248296880894730, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=¹ 山东第一医科大学第一附属医院（山东省千佛山医院）普通外科（山东济南 250000）)])])] 李庆麟,王海晨,孙俊英,韩绍奇,田虎. 甲胎蛋白显著升高的原发性肝小细胞神经内分泌癌1例[J]. 中国现代普通外科进展, 2026, 29(5): 417-420 DOI:10.3969/j.issn.1009-9905.2026.05.015

登录浏览全文

4963

注册一个新账户忘记密码

参考文献

原文顺序 | 出版日期 | 本文引用

[1]	Yao JC , Hassan M , Phan A , et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States[J]. J Clin Oncol, 2008, 26(18): 3063-3072. DOI: 10.1200/JCO.2007.15.4377.

[2]	Modlin IM , Lye KD , Kidd M . A 5—decade analysis of 13,715 carcinoid tumors[J]. Cancer, 2003, 97(4): 934-959. DOI: 10.1002/cncr.11105.

[3]	Wang HH , Liu ZC , Zhang G , et al. Clinical characteristics and outcome of primary hepatic neuroendocrine tumors after comprehensive therapy[J]. World J Gastrointest Oncol, 2020, 12(9): 1031-1043. DOI: 10.4251/wjgo.v12.i9.1031.

[4]	Pilichowska M , Kimura N , Ouchi A , et al. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases[J]. Pathol Int, 1999, 49(4): 318-324. DOI: 10.1046/j.1440—1827.1999.00866.x.

[5]	Quartey B . Primary hepatic neuroendocrine tumor: What do we know now? [J]. World J Oncol, 2011, 2(5): 209-216. DOI: 10.4021/wjon341w.

[6]	Li Z , Yong CC , Chen CL . A primary hepatic neuroendocrine tumor disguised as hepatocellular carcinoma[J]. Hepatobiliary Surg Nutr, 2020, 9(2): 263-266. DOI: 10.21037/hbsn.2020.01.02.

[7]	Gravante G , De Liguori Carino N , Overton J , et al. Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments[J]. Dig Surg, 2008, 25(5): 364-368. DOI: 10.1159/000167021.

[8]	Ergül N , Yilmaz B , Cin M , et al. 68Ga—DOTA—FAPI—04 PET/CT in neuroendocrine carcinoma of the liver with elevated AFP level: comparison with 18F—FDG PET/CT[J]. Clin Nucl Med, 2022, 47(1): e29-e31. DOI: 10.1097/RLU.0000000000003811.

[9]	La Salvia A , Fanciulli G . Beyond conventional biomarkers: the role of alpha—fetoprotein in gastroenteropancreatic neuroendocrine neoplasms[J]. Front Endocrinol (Lausanne), 2026, 17: 1778029. DOI: 10.3389/fendo.2026.1778029.

[10]	唐志明，徐宗珍 . CK19和Ki67在肝细胞癌组织中的表达及临床意义[J]. 中国现代普通外科进展， 2025， 28（11）： 905-907.

[11]	Sorbye H , Grande E , Pavel M , et al. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma[J]. J Neuroendocrinol, 2023, 35(3): e13249. DOI: 10.1111/jne.13249.

[12]

Morizane C , Machida N , Honma Y , et al. Effectiveness of etoposide and cisplatin vs irinotecan and cisplatin therapy for patients with advanced neuroendocrine carcinoma of the digestive system: the TOPIC—NEC phase 3 randomized clinical trial[J]. JAMA Oncol, 2022, 8(10): 1447-1455. DOI: 10.1001/jamaoncol.2022.3395.

[13]	Park CH , Chung JW , Jang SJ , et al. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas[J]. J Gastroenterol Hepatol, 2012, 27(8): 1306-1311. DOI: 10.1111/j.1440—1746.2012.07117.x.

[14]	Horn L , Mansfield AS , Szczęsna A , et al. First—line atezolizumab plus chemotherapy in extensive—stage small—cell lung cancer[J]. N Engl J Med, 2018, 379(23): 2220-2229. DOI: 10.1056/NEJMoa1809064.

[15]	Aly R , Gupta S , Potdar R . The role of immune checkpoint inhibitors in the treatment of extensive—stage extrapulmonary small cell carcinoma[J]. Cureus, 2020, 12(6): e8862. DOI: 10.7759/cureus.8862.

[16]	Gile JJ , McGarrah PW , Leventakos K , et al. Efficacy of first—line checkpoint inhibitors in combination with chemotherapy in high—grade extrapulmonary metastatic neuroendocrine carcinomas[J]. J Neuroendocrinol, 2023, 35(5): e13283. DOI: 10.1111/jne.13283.

[17]	Raj N , Chan JA , Wang SJ , et al. Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas[J]. Br J Cancer, 2023, 129(2): 291-300. DOI: 10.1038/s41416—023—02298—8.

[18]	Robinson MD , Livesey D , Hubner RA , et al. Future therapeutic strategies in the treatment of extrapulmonary neuroendocrine carcinoma: a review[J]. Ther Adv Med Oncol, 2023, 15: 17588359231156870. DOI: 10.1177/17588359231156870.

[19]	Serrano AG , Rocha P , Freitas Lima C , et al. Delta—like ligand 3 (DLL3) landscape in pulmonary and extra—pulmonary neuroendocrine neoplasms[J]. NPJ Precis Oncol, 2024, 8(1): 268. DOI: 10.1038/s41698—024—00739—y.

[20]	Dasari A , Mehta K , Byers LA , et al. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases[J]. Cancer, 2018, 124(4): 807-815. DOI: 10.1002/cncr.31124.

[21]	Sorbye H , Welin S , Langer SW , et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study[J]. Ann Oncol, 2013, 24(1): 152-160. DOI: 10.1093/annonc/mds276.